Chemoproteomics as a basis for post-genomic drug discovery.

[1]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[2]  A. Goldstein,et al.  Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Topliss,et al.  Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.

[4]  P. Willett,et al.  A Comparison of Some Measures for the Determination of Inter‐Molecular Structural Similarity Measures of Inter‐Molecular Structural Similarity , 1986 .

[5]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[6]  Marvin Johnson,et al.  Concepts and applications of molecular similarity , 1990 .

[7]  Yvonne C. Martin,et al.  A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..

[8]  P. Skolnick,et al.  Synthesis of benzo-fused benzodiazepines employed as probes of the agonist pharmacophore of benzodiazepine receptors. , 1994, Journal of medicinal chemistry.

[9]  Hans-Joachim Böhm,et al.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure , 1994, J. Comput. Aided Mol. Des..

[10]  David M. Rocke,et al.  Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.

[11]  D. E. Patterson,et al.  Designing Chemical Libraries for Lead Discovery , 1996 .

[12]  T. Reisine.  Opioid analgesics and antagonists , 1996 .

[13]  W. Guida,et al.  The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.

[14]  Yvonne C. Martin,et al.  Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..

[15]  Gennady M Verkhivker,et al.  Unraveling principles of lead discovery: from unfrustrated energy landscapes to novel molecular anchors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Onuchic,et al.  Theory of protein folding: the energy landscape perspective. , 1997, Annual review of physical chemistry.

[17]  J M Blaney,et al.  Computational approaches for combinatorial library design and molecular diversity analysis. , 1997, Current opinion in chemical biology.

[18]  Yvonne C. Martin,et al.  The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding , 1997, J. Chem. Inf. Comput. Sci..

[19]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[20]  H. Matter,et al.  Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. , 1997, Journal of medicinal chemistry.

[21]  Ajay,et al.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.

[22]  John H. Van Drie,et al.  Approaches to virtual library design , 1998 .

[23]  H O Villar,et al.  Protein affinity map of chemical space. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[24]  M. Justice,et al.  Functional genomics in the post-genome era. , 1998, Mutation research.

[25]  H. Kubinyi,et al.  A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.

[26]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[27]  Steven L. Dixon,et al.  Bioactive Diversity and Screening Library Selection via Affinity Fingerprinting , 1998, J. Chem. Inf. Comput. Sci..

[28]  Steven L. Dixon,et al.  Investigation of classification methods for the prediction of activity in diverse chemical libraries , 1999, J. Comput. Aided Mol. Des..

[29]  Robert S. Pearlman,et al.  Metric Validation and the Receptor-Relevant Subspace Concept , 1999, J. Chem. Inf. Comput. Sci..

[30]  R. Cramer,et al.  Prospective identification of biologically active structures by topomer shape similarity searching. , 1999, Journal of medicinal chemistry.

[31]  Yueh-Ching Chou,et al.  Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan , 1999, Brain Research.

[32]  David C. Spellmeyer,et al.  Chapter 28. Recent Developments in Molecular Diversity: Computational Approaches to Combinatorial Chemistry , 1999 .

[33]  Lenz,et al.  Chemical ligands, genomics and drug discovery. , 2000, Drug discovery today.

[34]  R. Cramer,et al.  Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries. , 2000, Journal of medicinal chemistry.

[35]  Suto,et al.  Designing chiral libraries for drug discovery. , 2000, Drug discovery today.

[36]  P Willett,et al.  Chemoinformatics - similarity and diversity in chemical libraries. , 2000, Current opinion in biotechnology.

[37]  Drews.  Drug discovery today - and tomorrow. , 2000, Drug discovery today.

[38]  P. Beroza,et al.  A rapid computational method for lead evolution: description and application to alpha(1)-adrenergic antagonists. , 2000, Journal of medicinal chemistry.

[39]  Jürgen Bajorath,et al.  Selected Concepts and Investigations in Compound Classification, Molecular Descriptor Analysis, and Virtual Screening , 2001, J. Chem. Inf. Comput. Sci..

[40]  D. Agrafiotis,et al.  Combinatorial informatics in the post-genomics era , 2002, Nature Reviews Drug Discovery.

[41]  R. Finnell,et al.  Molecular basis of environmentally induced birth defects. , 2003, Annual review of pharmacology and toxicology.

[42]  John E Eksterowicz,et al.  Evaluation of a novel shape-based computational filter for lead evolution: application to thrombin inhibitors. , 2002, Journal of medicinal chemistry.

[43]  L. Cassis,et al.  Errors introduced by a tritium label in position 8 of catecholamines , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.